Cisplatin
Showing 1 - 25 of 5,020
Pancreatic Adenocarcinoma, Homologous Recombination Deficiency Trial (Cisplatin)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Homologous Recombination Deficiency
- Cisplatin
- (no location specified)
Oct 18, 2023
Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)
Not yet recruiting
- Pancreatic Cancer
- Gemcitabine
- +2 more
-
Baltimore, MarylandSKCCC Johns Hopkins
Aug 16, 2023
Locally Advanced Cervical Cancer Trial in Xi'an (Zimberelimab, Albumin-bound Paclitaxel, Cisplatin)
Recruiting
- Locally Advanced Cervical Cancer
- Zimberelimab
- +2 more
-
Xi'an, Shaanxi, ChinaHongxi Zhao
Sep 20, 2023
Neuroendocrine Carcinoma of the Bladder, Bladder Cancer Trial (Adebrelimab, Etoposide, Cisplatin)
Not yet recruiting
- Neuroendocrine Carcinoma of the Bladder
- Bladder Cancer
- Adebrelimab
- +3 more
- (no location specified)
Oct 14, 2023
Locally Advanced Unresectable Esophageal Squamous Carcinoma Trial in Jinan, Tianjin (Docetaxel for Injection (Albumin-bound),
Not yet recruiting
- Locally Advanced Unresectable Esophageal Squamous Carcinoma
- Docetaxel for Injection (Albumin-bound)
- +4 more
-
Jinan, Shandong, China
- +1 more
Nov 16, 2023
Cholangiocarcinoma Trial in Houston (Pembrolizumab, Gemcitabine, Cisplatin)
Not yet recruiting
- Cholangiocarcinoma
- Pembrolizumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 21, 2023
Carcinoma, Cervix Carcinoma Trial in Fuzhou (Karelizumab combined with etoposide and cisplatin)
Not yet recruiting
- Carcinoma
- Cervix Carcinoma
- Karelizumab combined with etoposide and cisplatin
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital
Jun 9, 2023
Merkel Cell Carcinoma Trial in Milano, Siena, Verona (Pembrolizumab, Etoposide, Cisplatin or Carboplatin)
Not yet recruiting
- Merkel Cell Carcinoma
- Pembrolizumab, Etoposide, Cisplatin or Carboplatin
-
Milano, Italy
- +2 more
Oct 10, 2023
Ovarian Cancer, Malignant Tumor of Uterus Trial in New York (Sacituzumab, Cisplatin)
Not yet recruiting
- Ovarian Cancer
- Malignant Neoplasm of Uterus
- Sacituzumab
- Cisplatin
-
New York, New YorkIcahn School of Medicine at Mount Sinai Division of Hematology a
Sep 14, 2023
Drug Toxicity Trial in Rawalpindi (N-Acetylcysteine, Chemotherapy)
Active, not recruiting
- Drug Toxicity
-
Rawalpindi, Punjab, PakistanMedical Oncology department, Fauji Foundation Hospital
Aug 25, 2023
Neoadjuvent, PD-1 Inhibitor, Chemo Trial in Xi'an (Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin)
Recruiting
- Neoadjuvent
- +3 more
- Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
-
Xi'an, Shaanxi, China
- +2 more
Aug 17, 2023
Ototoxicity, Drug-Induced Trial in Cincinnati (Sodium Thiosulfate)
Recruiting
- Ototoxicity, Drug-Induced
- Sodium Thiosulfate
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Mar 6, 2023
HER2 Gene Mutation Trial in Shanghai (Injection of IAH0968+Gemcitabine+Cisplatin, Gemcitabine+Cisplatin)
Recruiting
- HER2 Gene Mutation
- Injection of IAH0968+Gemcitabine+Cisplatin
- Gemcitabine+Cisplatin
-
Shanghai, ChinaFudan University Affiliated Zhongshan Hospital
Aug 7, 2023
Unresectable Intrahepatic Cholangiocarcinoma Trial (Camrelizumab, Gemcitabine Injection, Cisplatin injection)
Not yet recruiting
- Unresectable Intrahepatic Cholangiocarcinoma
- Camrelizumab
- +4 more
- (no location specified)
Feb 17, 2023
Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)
Not yet recruiting
- Biliary Tract Carcinoma
- +2 more
- Gemcitabine
- +3 more
-
Madison, WisconsinUniversity of Wisconsin
Sep 15, 2023
Advanced Biliary Tract Cancer Trial (anlotinib+TQB2450+nab-paclitaxel+cisplatin)
Not yet recruiting
- Advanced Biliary Tract Cancer
- (no location specified)
Apr 2, 2023
Urinary Bladder Cancer Trial in Assiut (Carboplatin-Gemcitabine Cisplatin-Gemcitabine)
Recruiting
- Urinary Bladder Cancer
- Carboplatin-Gemcitabine Cisplatin-Gemcitabine
-
Assiut, EgyptAssiutU
Apr 22, 2023
Head Neck Cancer Trial in Billerica, Darmstadt (Xevinapant, Cisplatin, intensity-modulated radiation therapy (IMRT))
Not yet recruiting
- Head and Neck Cancer
- Xevinapant
- +2 more
-
Billerica, Massachusetts
- +1 more
Sep 20, 2023
Chemo;Advanced Gastric Cancer;Cisplatin;Disulfiram Trial in Hangzhou (disulfiram and cisplatin, cisplatin)
Not yet recruiting
- Chemotherapy;Advanced Gastric Cancer;Cisplatin;Disulfiram
- disulfiram and cisplatin
- cisplatin
-
Hangzhou, Zhejiang, ChinaHangzhou first people's Hospital
Dec 26, 2022
Advanced Cholangiocarcinoma Trial in Hangzhou (Lenvatinib, tislelizumab, gemcitabine and cisplatin, Gemcitabine and cisplatin)
Not yet recruiting
- Advanced Cholangiocarcinoma
- Lenvatinib, tislelizumab, gemcitabine and cisplatin
- Gemcitabine and cisplatin
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital, Zhejiang University School of Me
Apr 10, 2023
MGMT-Unmethylated Glioblastoma Trial (Etoposide Plus Cisplatin)
Not yet recruiting
- MGMT-Unmethylated Glioblastoma
- Etoposide Plus Cisplatin
- (no location specified)
Jan 12, 2023
Cholangiocarcinoma Non-resectable Trial in Chengdu (Candonilimab, Cisplatin, Gemcitabine)
Recruiting
- Cholangiocarcinoma Non-resectable
- Candonilimab
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Aug 4, 2023
Epithelial Ovarian Cancer, Acute Kidney Injury Due to Circulatory Failure Trial (Sodium Sulfate, Hydration, Cisplatin)
Not yet recruiting
- Epithelial Ovarian Cancer
- Acute Kidney Injury Due to Circulatory Failure
- Sodium Sulfate
- +2 more
- (no location specified)
May 17, 2023
Histological or Cytological Confirmed Stage ? and ?a Thymoma Trial in Shanghai (NAB-Paclitaxel plus Cisplatin, Cisplatin plus
Not yet recruiting
- Histological or Cytological Confirmed Stage Ⅲ and Ⅳa Thymoma
- NAB-Paclitaxel plus Cisplatin
- Cisplatin plus Epirubicin plus Cyclophosphamide
-
Shanghai, Shanghai, ChinaYian Zhang
Apr 17, 2023
Pentoxifylline, Cisplatin, Nephrotoxixcity Trial (Pentoxifylline 400 mg SR tablets, cisplatin with standard hydration with
Not yet recruiting
- Pentoxifylline, Cisplatin, Nephrotoxixcity
- Pentoxifylline 400 mg SR tablets
- cisplatin with standard hydration with normal saline
- (no location specified)
Nov 30, 2022